What is Kemp Proteins?
Kemp Proteins operates as a premier provider of gene-to-protein, hybridoma, and cell line development services. As a member of Six.02 Bioservices, the company functions as a critical partner for innovators in the biopharmaceutical, diagnostic, and vaccine development spaces. Their core competency lies in mitigating technical risk and optimizing productivity for complex protein-based products. By offering bespoke solutions for human and veterinary applications, Kemp Proteins has established itself as a high-authority service provider, effectively bridging the gap between early-stage research and commercial-scale production for life sciences enterprises.
How much funding has Kemp Proteins raised?
Kemp Proteins has raised a total of $5.2M across 2 funding rounds:
Debt
$150K
Other Financing Round
$5M
Debt (2020): $150K with participation from PPP
Other Financing Round (2022): $5M led by BroadOak Capital Partners
Key Investors in Kemp Proteins
BroadOak Capital Partners
BroadOak Capital Partners is a boutique financial institution specializing in direct investment and banking services for life sciences and biopharma services companies. The firm focuses on life sciences tools, diagnostics, and biopharma services, leveraging its in-house expertise and extensive networks to deliver exceptional results for its clients.
PPP
Public-Private Partnership
What's next for Kemp Proteins?
With this recent influx of capital, Kemp Proteins is positioned to accelerate its operational capacity and expand its service portfolio. The strategic focus will likely center on enhancing its technical infrastructure to meet the rising demand for high-quality protein development in the biopharma industry. By leveraging the expertise of its financial partners, the company is well-equipped to navigate the complexities of the life sciences market, potentially pursuing further integration within the Six.02 Bioservices ecosystem. Future milestones will likely involve scaling its cell line development capabilities and deepening its footprint in the veterinary and human diagnostic markets, ensuring long-term value creation for its stakeholders.
See full Kemp Proteins company page
